List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #631 to #680.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ADVENTAssessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
  2. AECGElectrocardiography
  3. AECSHay-Wells syndrome
  4. AEDAutomated external defibrillator
  5. AEGISAlternative Graft Investigational Study
  6. AENAcute esophageal necrosis
  7. AFAtrial fibrillation
  8. AF-CHFAtrial Fibrillation And Congestive Heart Failure
  9. AFASAKAtrial Fibrillation, Aspirin, Antikoagulation
  10. AFASAK-2Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study
  11. AFBAcid-fast
  12. AFB stainAcid-fast
  13. AFCAPSAFCAPS/TexCAPS Trial
  14. AFCAPS/TEXCAPSAFCAPS/TexCAPS Trial
  15. AFEAmniotic fluid embolism
  16. AFFIRMAtrial Fibrillation Follow-Up Investigation Of Rhythm Management
  17. AFI-TiazinPhenothiazine
  18. AFIBAtrial fibrillation
  19. AFLAtrial flutter
  20. AFLPAmplified fragment length polymorphism
  21. AFMAcute flaccid myelitis
  22. AFPAlpha-fetoprotein
  23. AFP-L3%AFP-L3
  24. AFP screeningAlpha-fetoprotein
  25. AFREGSArmed Forces Regression Study
  26. AF and ACSAtrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention
  27. AF and PCIAtrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention
  28. AF and valvular inetrventionAtrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention
  29. AF resident survival guideAtrial fibrillation resident survival guide
  30. AF triple therapyAtrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention
  31. AGA Guidelines for IBS testingIrritable bowel syndrome differential diagnosis#American Gastroenterological Association Guidelines for Diagnosis of IBS
  32. AGENTAngiogenic Gene Therapy
  33. AGENT-2Angiogenic Gene Therapy Trial 2
  34. AGENT-3A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
  35. AGERRAGE (receptor)
  36. AGISAdvanced Glaucoma Intervention Study
  37. AGL deficiencyGlycogen storage disease type III
  38. AGON SRFelodipine
  39. AGRANULOCYTOSISAgranulocytosis
  40. AGTCoombs test
  41. AHAutoimmune hepatitis
  42. AHAAmerican Heart Association
  43. AHA/ASA Guidelines for StrokeAHA/ASA guidelines for stroke
  44. AHA/ASA Guidelines for the Management of Spontaneous Intracerebral HemorrhageAHA/ASA guidelines for the management of spontaneous intracerebral hemorrhage
  45. AHA/ASA guidelines for strokeAHA, ASA guidelines for stroke
  46. AHA/ASA guidelines for the management of spontaneous intracerebral hemorrhageAHA, ASA guidelines for the management of spontaneous intracerebral hemorrhage
  47. AHA/Immune TPEvans syndrome
  48. AHCAlternating hemiplegia of childhood
  49. AHOAlbright's hereditary osteodystrophy
  50. AHRAryl hydrocarbon receptor

View ( | ) (20 | 50 | 100 | 250 | 500)